Jackie Pucci

From 4R to supramolecular chemistry, U.S. agriculture finds new ways to battle nitrogen leaching and boost fertilizer efficiency.

Volatility-reducing agents, lower use rates, and innovation in the pipeline signal growth for the category.

Biological market is already on the rebound from pandemic-related slowdown, with years of growth ahead.

Timing is the $64,000 question on fungicides — particularly in corn, where aerial application can add to already-high costs.

As corn rootworm returns with a vengeance, proceed with caution if trading down is under consideration.

Abundant trait choices notwithstanding, the outlook for seed is somewhat muted going to 2021, according to the nation’s top retailers. 

Leading weed control experts weigh in on what’s makes an effective herbicide program in 2021.

Having more choices is a good problem — but navigating dicamba uncertainty and COVID weigh on the retail seed business.

Ag players know this well: Opportunities arise out of challenges.

The not-unexpected move to re-register dicamba for over-the-top use on soybeans and cotton speaks volumes about the huge challenges facing U.S. agriculture.

2020 has brought major changes in the world’s top agrochemical-producing nations. It’s important to keep an eye on what these could mean for U.S. ag players.

STK has partnered with U.S. distributor Summit Agro USA to bring its bio-based crop protection products to the market, including Timorex Gold and now Regev.

The COVID-19 pandemic helps accelerate a growing trend toward a digital marketplace.

2,4-D and glufosinate weed control failures also on the rise as retailers, awaiting regulators’ decision on dicamba’s re-registration, face yet more uncertainty.

Senior writer Jackie Pucci provides an update on drift injury across the country.

CommoditAg’s John Demerly weighs in on how the winds have changed in favor of e-commerce during the pandemic.

The Ninth Circuit Court handed Corteva Agriscience and the agricultural industry a win on Wednesday by denying a petition to vacate the registration for Enlist Duo.

Petition requests a review of the decision by a panel of 11 judges from the Ninth Circuit instead of the three-judge panel that issued the previous decision.

Bayer will pay up to $400 million to resolve dicamba litigation and claims.

The settlement is the “right action at the right time for Bayer to bring a long period of uncertainty to an end,” said CEO Werner Baumann.